Literature DB >> 12515785

Radical prostatectomy as treatment for prostate cancer.

Michael A S Jewett1, Neil Fleshner, Lawrence H Klotz, Robert K Nam, John Trachtenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12515785      PMCID： PMC139318     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Radical prostatectomy or watchful waiting in early prostate cancer?

Authors:  D Robert Siemens
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

Review 2.  Prostate cancer: 2. Natural history.

Authors:  R K Nam; M A Jewett; M D Krahn
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

Review 3.  Prostate cancer: 4. Screening.

Authors:  F Meyer; Y Fradet
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

4.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

Authors:  Lars Holmberg; Anna Bill-Axelson; Fred Helgesen; Jaakko O Salo; Per Folmerz; Michael Häggman; Swen-Olof Andersson; Anders Spångberg; Christer Busch; Steg Nordling; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson; Bo Johan Norlén
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

5.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

6.  The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Authors:  Murray D Krahn; Karen E Bremner; Jamil Asaria; Shabbir M H Alibhai; Robert Nam; George Tomlinson; Michael A S Jewett; Padraig Warde; Gary Naglie
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

7.  Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.

Authors:  P C Albertsen; J A Hanley; D F Gleason; M J Barry
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

8.  Population-based study of long-term survival in patients with clinically localised prostate cancer.

Authors:  G L Lu-Yao; S L Yao
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

Review 9.  Prostate cancer: 1. The descriptive epidemiology in Canada.

Authors:  I G Levy; N A Iscoe; L H Klotz
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

10.  Long-term survival among men with conservatively treated localized prostate cancer.

Authors:  P C Albertsen; D G Fryback; B E Storer; T F Kolon; J Fine
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
  10 in total
  3 in total

1.  Pound of prevention, ounce of cure?

Authors: 
Journal:  CMAJ       Date:  2004-08-03       Impact factor: 8.262

2.  Synthesis and antiproliferative and apoptosis-inducing activity of novel 3-substituted-3-hydroxy-2-oxindole compounds.

Authors:  Mona Nazemi Moghaddam; Razieh Jalal; Zohreh Zeraatkar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-11-09       Impact factor: 2.416

3.  What is the consistency between the results of needle biopsy and prostatectomy specimen pathology results? A pilot study

Authors:  Ömer Ozan Yıldızlı; İbrahim Üntan; Deniz Demirci
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.